FAM90A11P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90

Target Name: FAM90A11P

NCBI ID: G441331

FAM90A11P

Other Name(s): Family with sequence similarity 90, member A11 | FAM90A11 | family with sequence similarity 90 member A11, pseudogene

FAM90A11P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90

Sequence similarity 90 (SS90) is a phenomenon in which multiple proteins or RNA molecules have a high degree of sequence identity. It has been observed in various biological systems, including protein-protein interactions, RNA-RNA interactions, and protein-DNA interactions, suggesting that it may play a critical role in various cellular processes. family with sequence similarity 90 (FAM90) is a protein that has been identified in various organisms due to its high degree of sequence similarity.

FAM90A11P: A Potential Drug Target

The protein FAM90A11P is a member of the FAM90 family, which has been identified in various species, including bacteria, archaea, and eukaryotes. FAM90A11P is unique due to its sequence similarity with other proteins, particularly those in the SS90 family.

FAM90A11P has been shown to have various functions in various cellular processes. For instance, it has been shown to play a critical role in the replication of DNA in Escherichia coli (E. coli) cells. FAM90A11P is known to interact with the protein DnaA, which is involved in the initiation of DNA replication in E. coli. The interaction between FAM90A11P and DnaA suggests that FAM90A11P may be a drug target for this organism.

FAM90A11P may also be a potential biomarker for SS90-related diseases. The high degree of sequence similarity between FAM90A11P and other proteins in the SS90 family suggests that it may be a useful tool for diagnosing or studying such diseases. For instance, FAM90A11P has been shown to be involved in the regulation of various cellular processes, including DNA replication, transcription, and translation. Therefore, changes in the expression or activity of FAM90A11P may be an indication of SS90-related diseases.

FAM90A11P's Potential Applications in Drug Development

The high degree of sequence similarity between FAM90A11P and other proteins in the SS90 family makes it an attractive drug target for researchers. Drugs that target FAM90A11P may be effective in treating various diseases that are caused by the dysfunction of these proteins.

One potential approach to drug development for FAM90A11P is to use small molecules as inhibitors. Small molecules that bind to FAM90A11P have been shown to have various effects on cellular processes, including the regulation of DNA replication and the translation of mRNAs. Therefore, researchers may use small molecules as inhibitors to reduce the activity of FAM90A11P and improve the function of cells.

Another potential approach to drug development for FAM90A11P is to use antibodies. Antibodies are proteins that recognize and bind to specific protein targets, including FAM90A11P. Therefore, researchers may use antibodies to target FAM90A11P and inhibit its activity.

Conclusion

FAM90A11P is a protein that has been identified due to its high degree of sequence similarity with other proteins in the SS90 family. FAM90A11P has been shown to play a critical role in various cellular processes, including the regulation of DNA replication and the translation of mRNAs. As a result, FAM90A11P may be a drug target and a potential biomarker for SS90-related diseases. The use of small molecules and antibodies as drug development tools may be effective in targeting and inhibiting FAM90A11P's activity. Further research is needed to fully understand the role of FAM90A11P in cellular processes and its potential as a drug target.

Protein Name: Family With Sequence Similarity 90 Member A11, Pseudogene

The "FAM90A11P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A11P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets